NO20006041L - N-Benzodioksanylmetyl-1-piperidyl-metylamin-forbindelser med affinitet for 5-HT-reseptorer - Google Patents

N-Benzodioksanylmetyl-1-piperidyl-metylamin-forbindelser med affinitet for 5-HT-reseptorer

Info

Publication number
NO20006041L
NO20006041L NO20006041A NO20006041A NO20006041L NO 20006041 L NO20006041 L NO 20006041L NO 20006041 A NO20006041 A NO 20006041A NO 20006041 A NO20006041 A NO 20006041A NO 20006041 L NO20006041 L NO 20006041L
Authority
NO
Norway
Prior art keywords
disorders
compounds
drug
disease
piperidylmethylamine
Prior art date
Application number
NO20006041A
Other languages
English (en)
Other versions
NO20006041D0 (no
Inventor
Neil Wishart
Alan Martin Birch
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO20006041L publication Critical patent/NO20006041L/no
Publication of NO20006041D0 publication Critical patent/NO20006041D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

Forbindelser med formel I. omfattende farmasøytisk akseptable salter derav hvor R representerer H eller F, deres fremstilling og anvendelse av dem ved behandling av depresjon, angst, psykoser, Parkinson's sykdom, fedme, hypertensjon, Tourette's syndrom, seksuell dysfunksjon, medikamentavhengighet, medikament-misbruk, kognitive lidelser, Alzheimer's sykdom, senil demens, tvangs-nevrotisk adferd, panikk-anfall, spiseforstyrrelser, anoreksi, kardiovaskulære og cerebrovaskulære lidelser, migrene, ikke-insulinavhengig diabetes mellitus, hyperglykemi, forstoppelse, arrytmi, lidelser i det neuroendocrine system, stress, prostatisk hypertrofi, medikament-fremkalte ekstrapyramidale symptomer eller spastisitet; er beskrevet.
NO20006041A 1998-06-03 2000-11-29 N-Benzodioksanylmetyl-1-piperidyl-metylamin-forbindelser med affinitet for 5-HT-reseptorer NO20006041D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9811879.7A GB9811879D0 (en) 1998-06-03 1998-06-03 Therapeutic agents
PCT/EP1999/003648 WO1999062902A1 (en) 1998-06-03 1999-05-26 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors

Publications (2)

Publication Number Publication Date
NO20006041L true NO20006041L (no) 2000-11-29
NO20006041D0 NO20006041D0 (no) 2000-11-29

Family

ID=10833098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006041A NO20006041D0 (no) 1998-06-03 2000-11-29 N-Benzodioksanylmetyl-1-piperidyl-metylamin-forbindelser med affinitet for 5-HT-reseptorer

Country Status (20)

Country Link
EP (1) EP1087964A1 (no)
JP (1) JP2002517392A (no)
KR (1) KR20010052526A (no)
CN (1) CN1304408A (no)
AR (1) AR018622A1 (no)
AU (1) AU4369599A (no)
BG (1) BG104988A (no)
BR (1) BR9910927A (no)
CA (1) CA2333756A1 (no)
CO (1) CO5021190A1 (no)
GB (1) GB9811879D0 (no)
HR (1) HRP20010005A2 (no)
HU (1) HUP0102233A2 (no)
ID (1) ID27067A (no)
IL (1) IL139552A0 (no)
NO (1) NO20006041D0 (no)
PL (1) PL344594A1 (no)
SK (1) SK17602000A3 (no)
TR (1) TR200003569T2 (no)
WO (1) WO1999062902A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915616D0 (en) * 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
GB0007376D0 (en) * 2000-03-28 2000-05-17 Knoll Ag Therapeutic agents
US6911448B2 (en) * 2000-05-12 2005-06-28 Solvay Pharmaceuticals B.V. Piperazine and piperidine compounds
WO2001085168A1 (en) * 2000-05-12 2001-11-15 Solvay Pharmaceuticals B.V. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
MXPA06012621A (es) * 2004-05-05 2006-12-15 Hoffmann La Roche Arilsulfonil benzodioxanos utiles para la modulacion del receptor 5-ht6, el receptor 5-ht2a o ambos.
CN101120002A (zh) 2005-02-17 2008-02-06 惠氏公司 环烷基稠合的吲哚、苯并噻吩、苯并呋喃和茚衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
FR2701479B1 (fr) * 1993-02-11 1995-05-12 Pf Medicament Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
GB9514380D0 (en) * 1995-07-13 1995-09-13 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
CN1304408A (zh) 2001-07-18
WO1999062902A1 (en) 1999-12-09
TR200003569T2 (tr) 2001-04-20
EP1087964A1 (en) 2001-04-04
JP2002517392A (ja) 2002-06-18
ID27067A (id) 2001-02-22
BR9910927A (pt) 2001-02-20
AR018622A1 (es) 2001-11-28
SK17602000A3 (sk) 2001-08-06
NO20006041D0 (no) 2000-11-29
KR20010052526A (ko) 2001-06-25
CA2333756A1 (en) 1999-12-09
GB9811879D0 (en) 1998-07-29
IL139552A0 (en) 2002-02-10
HRP20010005A2 (en) 2001-12-31
BG104988A (bg) 2001-11-30
PL344594A1 (en) 2001-11-05
AU4369599A (en) 1999-12-20
HUP0102233A2 (hu) 2002-05-29
CO5021190A1 (es) 2001-03-27

Similar Documents

Publication Publication Date Title
DE69423767D1 (de) 1,4-Benzodioxan-Derivate mit Affinität für D2 Rezeptoren und Nützlichkeit in der Behandlung von Psychosen
AR002830A1 (es) Nuevos compuestos de piperazina sustituida y procedimiento para prepararlos
TW413679B (en) Lactam derivatives useful as psychotherapeutic agents and pharmaceutical compositions containing them
AU1794097A (en) Tropane-derivatives, their preparation and use
Murata et al. Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 2: improvement of in vitro activity
BR0206513A (pt) Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos
EP0747353A3 (en) Indole derivatives
TWI237023B (en) Benzoxazinone derivatives, their preparation and use
WO2004022558A3 (en) Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
IL122540A0 (en) Heterocyclylcarboxamide derivatives their preparation and use
WO2002085896A8 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
CA2188949A1 (en) Benzofuran derivatives as d4 receptor antagonists
WO2001072741A3 (en) N-benzodioxanylmethyl-1-piperidyl-methylamine compounds for the treatment of central nervous system disorders
NO993172L (no) Sulfonamid-forbindelser med 5-HT-reseptor-aktivitet
JP2007538046A5 (no)
Corbel et al. 1-Benzazepine derivatives acting as ATP-dependent potassium-channels antagonists
BR9910927A (pt) Composto, composições farmacêuticas, processo para tratamento de depressão, ansiedade, psicoses, doença de parkinson, obesidade, hipertensão, sìndrome de tourette, disfunção sexual, toxicomania, abuso de droga, distúrbios cognitivos, doença de alzheimer, demência senil, comportamento obsessivo-compulsivo, ataques de pânico, indisposições alimentares, anorexia, distúrbios cardiovascular e cerebrovascular, enxaqueca, diabetes melitus não dependente de insulina, hiperglicemia, constipação, arritmia, distúrbios do sistema neuroendócrino, tensão, hipertrofia prostática, sintomas extrapiramidais induzidos por drogas ou espasticidade, uso de um composto, e, processo para preparação do composto
WO2002088146A3 (en) ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-e]INDOLE
TWI275588B (en) 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives
Wilbur et al. Gray's cybernetic theory of anxiety
NO20051617L (no) Piperidinderivater av heterocyklusfusjonerte benzodioksaner med antidepressiv aktivitet
MX9709509A (es) Agentes terapeuticos.
RU2000133316A (ru) N-бензодиоксанилметил-1-пиперидил-метиламины, обладающие сродством к рецепторам 5-нт
TW421647B (en) (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides
AR005368A1 (es) Compuestos de heteroarilcarboxamidas, las composiciones farmaceuticas que los contienen, la aplicacion de dichos compuestos para la preparacion demedicamentos, un metodo para tratar enfermedades con dichos compuestos y los procedimientos para preparar dichos compuestos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application